ΦΑΡΜΑΚΟΠΟΙΟΣ ΜΗ.ΣΥ ΣΥ.ΦΑ. Πυλώνας επαγγελµατικής. στα χρόνια της κρίσης. Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ. Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ

Μέγεθος: px

Εμφάνιση ξεκινά από τη σελίδα:

Download "ΦΑΡΜΑΚΟΠΟΙΟΣ ΜΗ.ΣΥ ΣΥ.ΦΑ. Πυλώνας επαγγελµατικής. στα χρόνια της κρίσης. Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ. Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ"

Μανασσῆς Κόρακας
7 χρόνια πριν
Προβολές:

1 ΦΑΡΜΑΚΟΠΟΙΟΣ Σύµβουλος Πρωτοβάθµιας Φροντίδας Υγείας ΜΗ.ΣΥ ΣΥ.ΦΑ Πυλώνας επαγγελµατικής και οικονοµικής ανάταξης στα χρόνια της κρίσης Πυλώνας επαγγελµατικής Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ

2 ΥΠΗΡΕΣΙΕΣ ΦΑΡΜΑΚΕΙΟΥ

3 ΕΛΛΑΔΑ Λιανικές Πωλήσεις από Φαρµακεία (IMS) 90 s 2005 ΤΕΜ Σε εκ ΤΕΜ Σε εκ ΤΕΜ Σε εκ ΑΞΙΑ Σε εκ ΑΞΙΑ Σε εκ ΑΞΙΑ Σε εκ. ΦΑΡΜΑΚΕΥΤΙΚΗ ΑΓΟΡΑ Εισαγόµενα vs Παραγόµενα 20% 80% % 50% 56% 44% 57% 43% 77% 23% 80% 20% 78% 22% Πρωτότυπα vs Ουσιωδώς Όµοια Αποζηµιούµενα vs ΜΗ Αποζηµ/να 88% 12% 78% 22% 84% 16% 74% 26% 84% 16% 78% 22% 89% 11% 93% 7% 84% 16% 92% 8% 84% 16% 93% 7% ΜΗΣΥΦΑ 59(16%) 190(4%) Αρνητική Λίστα 21(6%) 135(3%) Ασθενείς Ο-10-25% Ο-10-25% Ο-10-25% + Co-payment

4 Αύριο. Λιανικές Πωλήσεις Σε εκ * ΕΚΤΙΜΗΣΗ 2014* ΕΚΤΙΜΗΣΗ ΕΟΠΥΥ ΙΔΙΩΤΙΚΗ ΚΑΤΑΝΑΛΩΣΗ +ΣΥΜΜΕΤΟΧΗ Rx ΣΥΝΟΛΟ ΠΩΛΗΣΕΩΝ ΦΑΡΜΑΚΩΝ ΕΞΕΛΙΞΗ Μ.Κ.% στις Λιανικες Πωλήσεις 24% 19% 17,5% 15% Μ.Κ. ΑΠΟ ΦΑΡΜΑΚΑ ( ΠΟΡΤΕΣ ΦΑΡΜΑΚΕΙΩΝ). ΠΩΛΗΣΕΙΣ ΜΗΣΥΦΑ + ΑΡΝ.ΛΙΣΤΑ (24+5)% Μ.Κ.(OTC) Μ.Κ.ΠΑΡΑΦΑΡΜΑΚΑ+ΚΑΛΛΥΝΤΙΚΑ κλπ 150* 100* 90* 100* ΣΥΝΟΛΙΚΟΣ ΤΖΙΡΟΣ ΣΥΝΟΛΙΚΟ ΜΙΚΤΟ ΚΕΡΔΟΣ

5 UK PAGB: Driving the Self Care Agenda IMS Health Management Consulting & selfcareforum WHY NOW? Ageing population Growth of chronic conditions Increasing levels of obesity Binge drinking culture Economic position BETTER SELF-CARE IS GOOD FOR PROFESSIONALS Releases GP time Increases GP income Increases respect for pharmacist Consistency enhances public compliance NICE guidance on antibiotics

6 MINOR AILMENTS 50 million consultations per year 70% receive prescription for OTC Benefits from increased Self Care vs GP Consultation for MAs (Source:PAGP/IMS UK) 100% 18% % 60% 40% 82% % 0% GPs (Consultations) Prescriptions (million) Cost (Bn ) Minor Ailments Alone 18% 52 2 Severe Diseases 82% PAGB/ IMS Health Management Consulting/UK2011

7 ΠΟ ΛΙΤ ΕΣ ΦΑΡΜΑΚΟΠΟΙΟΙ ΙΑΤΡΟΙ 1 'Self care A real choice, Self care support a practical option', published by Department of Health, 2005 /UK

8 USA Source : The Value of OTC Medicines to the United States Booz&Co Jan.2012

12 FR ΑΣΦΑΛΕΙΑ -ΕΚΠΑΙΔΕΥΣΗ ANSM Dominique Maraninchi, Directeur Général Self-medication in France Safety is the first preoccupation of French Authorities Specific workgroup on self-medication Benefit-Risk evaluation all along the product life Evaluation, Inspection, Control Collaboration with other Health Agencies European network : social, safety, regulation, inspections and controls

13 EE(30) EPSA Tiia Metiäinen, EPSA Vice President of Education Representing over pharmacy students from over 30 European countries Responsibility - Opportunity - Future solutions If pharmacists, as advisers, don t know the way how to correctly transfer their knowledge or how to approach a patient with a specific condition, their knowledge would be useless regarding self-care

14 EE Access+ Information+ Support= Consumer empowerment Το 70% προτιµά την αυτοφροντίδα, έναντι 20% που προστρέχει στο NHS WHICH?, 2010

15 Sales out of control BEUC members mystery shopping for a weight loss medicine (Orlistat) For adults with BMI 28 kg/m2; not suitable for pregnant and breast feeding women; requires special care in case of diabetes, use of oral contraceptive, kidney disease, use of other medicines etc. UK ( May 2009) - Ireland ( September 2009); - Spain ( July 2009) Belgium (October 2009) - Portugal ( February 2010) - Italy (May 2010) - Austria ( April 2011) Disappointing results: ØIn 70 % of the 86 pharmacies visited in Spain the product was sold to consumers with a BMI between 18 and 24. ØIn 74% of the 103 pharmacies visited in Italy the product was sold to consumers with a BMI < 28. In most cases it was sold without any question on the consumer weight and possible health problems and with no advice on healthy diet/physical activity. ØIn 10 out of 16 pharmacies in Vienna the product was sold to a 15 years old girl with BMI of 19,4 and in 6 of them the product was sold to a breast feeding mother with a BMI of 25,1.

16 EE (27) representative of National Medical Associations of 27 European countries members of the EU Never treat a symptom treat a disease Self-medication is not appropriate and you should consult a medical doctor in the following situations: your symptoms have persisted your condition worsens or recurs worse than before you have severe pain you have tried one or more medicines without success you experience unwanted effects you think your symptoms are serious you have psychological problems like anxiety, unease, depression specific attention should be paid to certain groups, such as pregnant or breastfeeding women, babies and infants

17 In 1997 AESGP, Doctors (CPME, UEMO and UEMS) and Pharmacists (PGEU) agreed: All parties associated with self-medication must seek to ensure that all medicines supplied without medical prescription are appropriate for the user and that sufficient and relevant information is given to provide maximum therapeutic benefit and safety in use.

Σχετικά έγγραφα

Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ

ΜΗ.ΣΥ.ΦΑ Πυλώνας επαγγελματικής και οικονομικής ανάταξης στα χρόνια της κρίσης Βασίλης Σ. Σερέτης Πρόεδρος ΕΦΕΧ Βασίλης Σ. Σερέτης 4η ΗΜΕΡΙΔΑ ΦΑΡΜΑΚΟΠΟΙΩΝ, Πρόεδρος ΕΦΕΧ20/1/2013 Pharmacy management ΙΣΤΟΡΙΚΑ::